The MAPT H1 haplotype is associated with tangle-predominant dementia
暂无分享,去创建一个
K. Dewar | Xinmin Liu | L. Clark | P. Nelson | J. Crary | I. Santa-Maria | Jessica Wasserscheid | A. Haggiagi | I. Santa-María | Aya Haggiagi
[1] W. Jagust,et al. Discrepant diagnostic classification with AV45-PET and FDG-PET of clinically diagnosed Alzheimer's patients in the Alzheimer's Disease Neuroimaging Initiative , 2012, Alzheimer's & Dementia.
[2] E. Junn,et al. MicroRNAs in neurodegenerative diseases and their therapeutic potential. , 2012, Pharmacology & therapeutics.
[3] J. Schneider,et al. National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease , 2012, Alzheimer's & Dementia.
[4] Sarah A. Chau,et al. Current and Emerging Drug Treatment Options for Alzheimer’s Disease , 2011, Drugs.
[5] R. Petersen,et al. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study , 2011, The Lancet Neurology.
[6] A. Simon,et al. Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex , 2011, Journal of neuroscience research.
[7] J. Hardy,et al. Disentangling the role of the tau gene locus in sporadic tauopathies. , 2010, Current Alzheimer research.
[8] I. Mata,et al. The Genetics of Parkinson Disease , 2010, Journal of geriatric psychiatry and neurology.
[9] R. V. Van Heertum,et al. Pittsburgh Compound B (11C-PIB) and Fluorodeoxyglucose (18 F-FDG) PET in Patients With Alzheimer Disease, Mild Cognitive Impairment, and Healthy Controls , 2010, Journal of geriatric psychiatry and neurology.
[10] A. McKee,et al. Mild traumatic brain injury: a risk factor for neurodegeneration , 2010, Alzheimer's Research & Therapy.
[11] C. Jack,et al. Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects , 2010, Alzheimer's & Dementia.
[12] M. Owen,et al. An association study of common variation at the MAPT locus with late‐onset Alzheimer's disease , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[13] Carol Brayne,et al. Age, neuropathology, and dementia. , 2009, The New England journal of medicine.
[14] Michael J. Owen,et al. The effect of age and the H1c MAPT haplotype on MAPT expression in human brain , 2009, Neurobiology of Aging.
[15] Charles D. Smith,et al. Brains With Medial Temporal Lobe Neurofibrillary Tangles But No Neuritic Amyloid Plaques Are a Diagnostic Dilemma But May Have Pathogenetic Aspects Distinct From Alzheimer Disease , 2009, Journal of neuropathology and experimental neurology.
[16] K. Marder,et al. Association of glucocerebrosidase mutations with dementia with lewy bodies. , 2009, Archives of neurology.
[17] E. Koo,et al. Amyloid Precursor Protein Trafficking, Processing, and Function* , 2008, Journal of Biological Chemistry.
[18] M. Tabaton,et al. Evidence that the Amyloid beta Precursor Protein-intracellular domain lowers the stress threshold of neurons and has a "regulated" transcriptional role , 2008, Molecular Neurodegeneration.
[19] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[20] J. Schneider,et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration , 2007, Acta Neuropathologica.
[21] D. Selkoe,et al. Aβ Oligomers – a decade of discovery , 2007, Journal of neurochemistry.
[22] M. Spillantini,et al. Frontotemporal Dementia with Tau Pathology , 2007, Neurodegenerative Diseases.
[23] A. Myers,et al. The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts , 2007, Neurobiology of Disease.
[24] John X. Morris,et al. The Fat of the Land: Do Agricultural Subsidies Foster Poor Health? , 2004, BMC Genetics.
[25] K. Jellinger,et al. Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease , 2007, Acta Neuropathologica.
[26] T. Iwaki,et al. Quantitative analysis of neurofibrillary pathology in a general population to reappraise neuropathological criteria for senile dementia of the neurofibrillary tangle type (tangle‐only dementia): The Hisayama study , 2006, Neuropathology : official journal of the Japanese Society of Neuropathology.
[27] H. Akiyama,et al. Immunohistochemical investigation of neurofibrillary tangles and their tau isoforms in brains of limbic neurofibrillary tangle dementia , 2006, Neuroscience Letters.
[28] T. Sacktor,et al. Atypical Protein Kinase C in Neurodegenerative Disease I: PKM&zgr; Aggregates With Limbic Neurofibrillary Tangles and AMPA Receptors in Alzheimer Disease , 2006, Journal of neuropathology and experimental neurology.
[29] N. Ghebranious,et al. Detection of ApoE E2, E3 and E4 alleles using MALDI-TOF mass spectrometry and the homogeneous mass-extend technology , 2005, Nucleic acids research.
[30] A M Pittman,et al. The H1c haplotype at the MAPT locus is associated with Alzheimer's disease. , 2005, Human molecular genetics.
[31] A J Lees,et al. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration , 2005, Journal of Medical Genetics.
[32] H. Stefánsson,et al. A common inversion under selection in Europeans , 2005, Nature Genetics.
[33] A. Andreadis. Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases. , 2005, Biochimica et biophysica acta.
[34] C. DeCarli,et al. Neutralization of Transthyretin Reverses the Neuroprotective Effects of Secreted Amyloid Precursor Protein (APP) in APPSw Mice Resulting in Tau Phosphorylation and Loss of Hippocampal Neurons: Support for the Amyloid Hypothesis , 2004, The Journal of Neuroscience.
[35] M. Yamada. Senile dementia of the neurofibrillary tangle type (tangle‐only dementia): Neuropathological criteria and clinical guidelines for diagnosis * , 2003, Neuropathology : official journal of the Japanese Society of Neuropathology.
[36] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[37] R. Mohs,et al. Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.
[38] D. Dickson,et al. Morphological and Biochemical Correlations of Abnormal Tau Filaments in Progressive Supranuclear Palsy , 2002, Journal of neuropathology and experimental neurology.
[39] L. Behar,et al. Axonal Tau mRNA Localization Coincides with Tau Protein in Living Neuronal Cells and Depends on Axonal Targeting Signal , 2001, The Journal of Neuroscience.
[40] K. Blennow,et al. Reduced Expression of Amyloid Precursor Protein, Presenilin-1 and rab3a in Cortical Brain Regions in Alzheimer’s Disease , 2001, Dementia and Geriatric Cognitive Disorders.
[41] E. Otomo,et al. Senile Dementia of the Neurofibrillary Tangle Type: A Comparison with Alzheimer’s Disease , 2001, Dementia and Geriatric Cognitive Disorders.
[42] M. Tabaton,et al. Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy , 2000, Annals of neurology.
[43] R. Marx,et al. Identification of 3′UTR region implicated in tau mRNA stabilization in neuronal cells , 1999, Journal of Molecular Neuroscience.
[44] I Litvan,et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. , 1999, Human molecular genetics.
[45] J. Morris,et al. Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease , 1999, Annals of neurology.
[46] Masanori Kato,et al. Clinical Aspects of ‘Senile Dementia of the Tangle Type’ – A Subset of Dementia in the Senium Separable from Late-Onset Alzheimer’s Disease , 1998, Dementia and Geriatric Cognitive Disorders.
[47] K. Jellinger,et al. Senile Dementia with Tangles (Tangle Predominant Form of Senile Dementia) , 1998, Brain pathology.
[48] J Bohl,et al. Staging of Alzheimer-Related Cortical Destruction , 1997, International Psychogeriatrics.
[49] H. Akiyama,et al. A subset of senile dementia with high incidence of the apolipoprotein E ϵ2 allele , 1997 .
[50] J. Morris,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XIII. , 1996, Neurology.
[51] J. Morrison,et al. Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital. , 1994, Cerebral cortex.
[52] J. Wall,et al. Mass and physical dimensions of two distinct populations of paired helical filaments , 1994, Neurobiology of Aging.
[53] V. Ambros,et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.
[54] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[55] P. Lansbury,et al. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.
[56] M. Mattson,et al. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein , 1993, Neuron.
[57] J. Rowe,et al. Human aging: usual and successful. , 1987, Science.
[58] H. Horvitz,et al. The lin-14 locus of Caenorhabditis elegans controls the time of expression of specific postembryonic developmental events. , 1987, Genes & development.
[59] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[60] M. Kidd. Paired Helical Filaments in Electron Microscopy of Alzheimer's Disease , 1963, Nature.
[61] Charles Duyckaerts,et al. National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach , 2011, Acta Neuropathologica.
[62] S. Schmidt,et al. Tissue processing prior to protein analysis and amyloid-beta quantitation. , 2005, Methods in molecular biology.
[63] S. Schmidt,et al. Tissue Processing Prior to Protein Analysis and Amyloid-ß Quantitation , 2005 .
[64] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[65] K. Jellinger,et al. Neurofibrillary tangle predominant form of senile dementia of Alzheimer type: a rare subtype in very old subjects , 2004, Acta Neuropathologica.
[66] H. Akiyama,et al. A subset of senile dementia with high incidence of the apolipoprotein E epsilon2 allele. , 1997, Annals of neurology.
[67] K. Iqbal,et al. Alzheimer's disease : biology, diagnosis, and therapeutics , 1996 .
[68] M A Pericak-Vance,et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. , 1993, Neurology.
[69] J. Ulrich. Abundant neurofibrillary tangles without senile plaques in a subset of patients with senile dementia , 1992 .